Three Good Things (3GT) - Intervention for Transitional Care Patients

Three Good Things (3GT) - Intervention for Transitional Care Patients at the Mayo Clinic Bloomer Critical Access Hospital

Researchers are doing this research study to learn how the Three Good Things (3GT) Positive Psychology journaling activity affects symptoms of stress, depression, resilience, and happiness.

Study Overview

• Status: Terminated
• Conditions: Resilience, Psychological; Psychology, Positive; Positive Thinking
• Intervention / Treatment: Behavioral: Three Good Things (3GT) Positive Psychology journaling activity

Detailed Description

The purpose of this study is to measure, rank and categorize the subject sample of depression, stress, resilience and happiness scores using quantitative surveys. This research aims to learn how a Three Good Things (3GT) journaling activity affects a subject's symptoms of stress, depression, resilience and happiness. The data will allow the project team to gain an in-depth understanding of the impact of the use of resilience strategies from a hospitalized patient's perspective. The project aims to review if there is a correlation between stress, depression, resiliency, and happiness scores to the use of Positive Psychology.

• Study Type: Interventional
• Enrollment (Actual): 25
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • Wisconsin
    • Bloomer, Wisconsin, United States, 54724
      • Mayo Clinic Health System Bloomer Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Individuals ≥ 18 years of age.
• Current inpatient at the Mayo Clinic Health System Bloomer Hospital, Bloomer, Wisconsin (a Swing Bed Hospital as defined by the Center for Medicare and Medicaid Services (CMS)).
• Able to speak English.
• Able to answer questionnaires.

Exclusion Criteria:

• Individuals < 18 years of age.
• Patient unwilling or unable to provide consent to participate in this research study.
• Patient under guardianship.
• As determined through self-report, patient in active psychosis, active suicidal ideation, active substance abuse meeting criteria for substance use disorders except for nicotine (the exception is patients with a history of substance abuse that have been in remission for at least one full year).
• Patient diagnosed with obsessive-compulsive disorder, active panic disorder with agoraphobia or other phobic disorder, active Post Traumatic Stress Disorder, or active severe personality disorders.
• Patient with previous participation in this study.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Supportive Care
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: 3GT journaling group; Subjects will participate in the Three Good Things (3GT) Positive Psychology journaling activity daily for six weeks.	Behavioral: Three Good Things (3GT) Positive Psychology journaling activity; Evening journaling activity each day to reflect on three good things that the subject has noticed about their day's events.
No Intervention: Non-journaling group; Subjects will not participate in the evening journal activity.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Perceived Stress	Change in subject perceived stress measured using the self-reported perceived stress scale (PSS). A 10-item questionnaire assessing individuals' appraisal of stress using a scale of 0=never, 4=very often.	Baseline, 6 weeks

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Subjective Depression	Change in subject depression measured using the Center for Epidemiologic Studies Depression Scale-Revised (CESD-R-10).	Baseline, 6 weeks
Subjective Happiness	Change in subject happiness measured using the self-reported subjective happiness scale (SHS). A 4-item scale of global subjective happiness. Two items ask respondents to characterize themselves using both absolute ratings and ratings relative to peers, whereas the other two items offer brief descriptions of happy and unhappy individuals and ask respondents the extent to which each characterization describes them.	Baseline, 6 weeks
Subjective Resilience	Change in subject resiliency scores measured by the Connor-Davidson Resilience Scale (CD-RISC 2)	Baseline, 6 weeks

Collaborators and Investigators

• Sponsor: Mayo Clinic
• Investigators: Principal Investigator: Lori M Miller, MAOM, RN, Mayo Clinic

Publications and helpful links

Helpful Links

• Mayo Clinic Clinical Trials

Study record dates

Study Major Dates

• Study Start (Actual): September 30, 2021
• Primary Completion (Actual): December 1, 2023
• Study Completion (Actual): December 1, 2023

Study Registration Dates

• First Submitted: July 19, 2021
• First Submitted That Met QC Criteria: July 19, 2021
• First Posted (Actual): July 21, 2021

Study Record Updates

• Last Update Posted (Actual): April 10, 2024
• Last Update Submitted That Met QC Criteria: April 8, 2024
• Last Verified: April 1, 2024

More Information

Terms related to this study

• Other Study ID Numbers: 21-003878

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO
• IPD Plan Description: There is no plan to share individual participant data to other researchers.

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No